At the centre of this shift is Eli Lilly and Company, whose latest investments in China and Japan are helping redefine the next phase of GLP-1 supply strategy
The first of four planned modules at the new plant is expected to come online by summer 2026
Backed by a multi-hundred-million-dollar investment, the expansion underscores Sanofi’s long-term commitment to India’s thriving life sciences ecosystem
The multimillion-dollar facility combines discovery and early-phase scale-up capabilities with R&D labs and two pilot plants
The additional production will raise the installed capacity by 400 million and available capacity by 240 million at the facility
Company plans to create 100 manufacturing jobs and up to 1,000 construction jobs
The new CMC Process R&D Center represents a strategic investment in scale, sustainability, and specialization
With this expansion, the overall fermentation capacity of the company has increased from 450 KL to 990 KL
With this addition, the company’s total Installed MCC Capacity will rise to 30,000 MTPA
Subscribe To Our Newsletter & Stay Updated
